Cabroncita Friday, 10/06/17 11:50:10 AM Re: None Post # of 1830670 $AEPP According to Florida Hospital, approximately 80,000 women receive a gynecological cancer diagnosis in the United States each year. About half of all gynecological cancer diagnoses are uterine cancer, which contributes to 8,000 deaths each year while ovarian cancer causes 16,000 deaths annually. Oncolix saw a need for an improvement in the current treatment protocol, thus arose Prolanta (G129R). http://smallcapvoice.com/blog/oncolix-creates-a-drug-that-could-change-gynecological-cancer-treatment/ Consider all my posts my opinion and not advice to buy or sell anything. I post on stocks I own or am considering owning. Do your own DD!